Virtual Library

Start Your Search

Jonida Tula



Author of

  • +

    EP1.12 - Small Cell Lung Cancer/NET (ID 202)

    • Event: WCLC 2019
    • Type: E-Poster Viewing in the Exhibit Hall
    • Track: Small Cell Lung Cancer/NET
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
    • +

      EP1.12-32 - Clinico-Pathological Features of Small Cell Lung Cancer in Albanian Patients (ID 284)

      08:00 - 18:00  |  Author(s): Jonida Tula

      • Abstract
      • Slides

      Background

      Lung cancer is the leading cause of cancer-related death in the world. Small cell lung cancer (SCLC) is an aggressive type of lung cancer and accounts for 15% of all lung cancer cases. Progress in the survival rate of SCLC is poor with a 5-year survival rate of only 5-10%, depending on tumour stage at presentation.

      Method

      Purpose of this study was to describe.1- the main characteristics of small cell lung cancer and overall survival of these patients.

      Methods: All patients with SCLC were evaluated in the main university hospital for lung diseases. Demographic, clinical, histological characteristics were reviewed.

      Result

      153 patients diagnosed with sclc between 2015 and 2018 were included. this counts 5.8 % of all lung cancer patients ( n=2598 ) .The mean age was 62,2 +/- 4,0 years, with the majority being men (93%). 88.2 % of patients had a smoking history. 12% of them were presented with liver metastasis.

      The median overall survival was 6,1 months after the diagnosis.

      Twelve patients had a previous familiar cancer history.

      At diagnostic, the most frequent symptoms were cough (65%) and dyspnea (51,3%). The mean time between the first symptoms and diagnosis was 123 +/- 89 days.

      Conclusion

      Small cell lung cancer is an agressive tumor with low overall survival because albanian patients come later to the health care profesionists and are heavy smokers.

      Policies for smoking cessation should be strengthened and a lung cancer screening program should be initiated.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.